US biopharmaceutical company plans USD 6m IT investment in Romania by end-2016
World biotechnology and personlized therapies leader company Amgen, based in USA, is present on the Romanian market for 5 years, with over USD 40 m turnover in 2014, mainly offering targeted therapies in oncology, osteoporosis, rare…